Show simple item record

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorZaiss, D.
dc.contributor.advisorSijts, A.
dc.contributor.authorYilmaz, V.
dc.date.accessioned2012-08-24T17:01:06Z
dc.date.available2012-08-24
dc.date.available2012-08-24T17:01:06Z
dc.date.issued2012
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/14945
dc.description.abstractCancer is the leading cause of death in economically developed countries and the conventional anti-cancer therapies fail to meet the criteria of an ideal, safe and highly effective therapy especially against the metastatic cancer types. Cancer immunotherapy is an up-coming anti-cancer therapy that uses the patient’s own immune system to target and kill the cancer cells. There are several different strategies and approaches to the cancer immunotherapy in respect to the diverse hallmarks of cancer. While some of these immunotherapeutic agents are approved and made their way into practice, some needs further development and assessment in trials. This study aims to review the already accepted and newly developing immunotherapies against cancer and also to shed light on the issues associated with cancer immunotherapy that determine its failures, successes and future in clinical studies and medical practice.
dc.description.sponsorshipUtrecht University
dc.format.extent867161 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.titleCancer Immunotherapy
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.keywordsCancer, Immunotherapy, cancer immunology, cancer treatment
dc.subject.courseuuMolecular and Cellular Life Sciences


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record